Investigation of Oral Microflora of Infants

Overview

The placement of cariogenic microorganisms in oral microflora is an important factor in dental caries. The aim of this study is to research from whom, when and how the cariogenic microorganisms are first transmitted to the infant. The investigators investigated of colonization of Streptococcus mutans, Lactobacillus spp., and Candida spp. in oral cavities of infants and their transmission to the infants.

Full Title of Study: “Investigation of Colonization of Streptococcus Mutans, Lactobacillus Spp. and Candida Spp. in Oral Microflora in Infancy and Transmission From the Parent to the Infant”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 20, 2018

Detailed Description

Study sample size and design: When α = 0.05, 1-β (power) = 0.80 were taken to determine the sample volume, it was calculated that at least 46 babies should be sampled for 6 months to have an average amount of S. mutans change of 1.87 units. Considering the losses that may occur during the follow-up, the study was started by taking samples from 60 systemically healthy newborns.

The study commenced with 60 newborns and was completed with 47 infants due to losses during the follow-up. Oral swab samples were taken from 47 healthy infants within the first 24 hours after birth, at 1 month old and during the first tooth eruption. Saliva samples were taken from the mothers of all the infants and from the fathers of 20 of the infants in the last meeting.

Last interview with the parents, their oral examinations were performed, and their findings were processed as decayed (D), filled (F) and missing (M) teeth in accordance with the World Health Organization criteria, with the DMF (decayed, missing and filled) index being calculated. Furthermore, saliva samples were taken from the parents at the last interview. A questionnaire form including the sex of the infant, type of delivery, birth weight, and nutritional habits of the infant during the follow-up was filled in by gaining information from the parents on the first day and during the follow-ups.

Swab samples taken from infants with sterile swabs were transferred to the laboratory by placing sterile saline solution into dispensed 2 ml screw cap tubes. Sterile urine collection containers of 50 ml were used to collect saliva samples from the parents.

Clinical Trial Outcome Measures

Primary Measures

  • Acquisition of the oral streptococcus mutans in infants
    • Time Frame: first 24 hours after birth
    • Counts of oral streptococcus mutans
  • Acquisition of the oral streptococcus mutans in infants
    • Time Frame: at 1 month old
    • Counts of oral streptococcus mutans
  • Acquisition of the oral streptococcus mutans in infants
    • Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
    • Counts of oral streptococcus mutans

Secondary Measures

  • Acquisition of the oral Lactobacillus and candida spp. in infants
    • Time Frame: first 24 hours after birth
    • Counts of oral Lactobacillus and candida spp
  • Acquisition of the oral Lactobacillus and candida spp. in infants
    • Time Frame: at 1 month old
    • Counts of oral Lactobacillus and candida spp
  • Acquisition of the oral Lactobacillus and candida spp. in infants
    • Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
    • Counts of oral Lactobacillus and candida spp

Participating in This Clinical Trial

Inclusion Criteria

  • none of the infants or their families had systemic disease

Exclusion Criteria

  • the infants or their families have systemic disease

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: 2 Hours

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Inonu University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Zehra Beyza Erel, research assistant – Inonu University
  • Overall Official(s)
    • gülsüm duruk, Study Director, Inonu University
    • zehra b erel, Principal Investigator, Inonu University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.